Application

ZYNRELEF

Heron Therapeutics, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90173827
Filing Date: 09/11/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90173827
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\901\738\90173827\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT ZYNRELEF
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word "ZYNRELEF" in stylized lettering with one thick curved line above the "YNREL" portion of the mark and another thinner curved line above the thick curved line.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 944 x 335
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Heron Therapeutics, Inc.
*MAILING ADDRESS 4242 Campus Point Court, Suite 200
*CITY San Diego
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92121
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances, namely, anesthetics for surgical purposes; anesthetics for surgical use; inhalant anesthetics; local anesthetics; topical anesthetics; general anesthetics; anti-inflammatory preparations; anti-inflammatory ointments; analgesic preparations; preparations for the relief of pain; anesthetics for peri-operative and post-operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain; all of the foregoing excluding pharmaceutical preparations and substances for treatment or management of sleep disorders, namely, narcolepsy
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Beth M. Goldman
ATTORNEY DOCKET NUMBER 21539-6000
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Orrick, Herrington & Sutcliffe LLP
INTERNAL ADDRESS IP Prosecution Department
STREET 2050 Main Street, Suite 1100
CITY Irvine
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 92614-8255
PHONE 415-773-5700
FAX 949-567-6710
EMAIL ADDRESS ipprosecutionsf@orrick.com
OTHER APPOINTED ATTORNEY Betsy Wang Lee, Eileen Z. Aghnami, Kristin S. Cornuelle, Diana M. Rutowski, Peter D. Vogl, Briggs M. Wright, Robert M. O'Connell Jr.
CORRESPONDENCE INFORMATION
NAME Beth M. Goldman
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ipprosecutionsf@orrick.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) beth.goldman@orrick.com; blee@orrick.com; eaghnami@orrick.com; aparker@orrick.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /Thomas Ottoboni/
SIGNATORY'S NAME Thomas Ottoboni
SIGNATORY'S POSITION Senior VP
SIGNATORY'S PHONE NUMBER 415-773-5700
DATE SIGNED 09/10/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90173827
Filing Date: 09/11/2020

To the Commissioner for Trademarks:

MARK: ZYNRELEF (stylized and/or with design, see mark)
The literal element of the mark consists of ZYNRELEF. The applicant is not claiming color as a feature of the mark. The mark consists of the word "ZYNRELEF" in stylized lettering with one thick curved line above the "YNREL" portion of the mark and another thinner curved line above the thick curved line.
The applicant, Heron Therapeutics, Inc., a corporation of Delaware, having an address of
      4242 Campus Point Court, Suite 200
      San Diego, California 92121
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations and substances, namely, anesthetics for surgical purposes; anesthetics for surgical use; inhalant anesthetics; local anesthetics; topical anesthetics; general anesthetics; anti-inflammatory preparations; anti-inflammatory ointments; analgesic preparations; preparations for the relief of pain; anesthetics for peri-operative and post-operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain; all of the foregoing excluding pharmaceutical preparations and substances for treatment or management of sleep disorders, namely, narcolepsy
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




The owner's/holder's proposed attorney information: Beth M. Goldman. Other appointed attorneys are Betsy Wang Lee, Eileen Z. Aghnami, Kristin S. Cornuelle, Diana M. Rutowski, Peter D. Vogl, Briggs M. Wright, Robert M. O'Connell Jr.. Beth M. Goldman of Orrick, Herrington & Sutcliffe LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      IP Prosecution Department
      2050 Main Street, Suite 1100
      Irvine, California 92614-8255
      United States
      415-773-5700(phone)
      949-567-6710(fax)
      ipprosecutionsf@orrick.com
The docket/reference number is 21539-6000.
Beth M. Goldman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Beth M. Goldman
       PRIMARY EMAIL FOR CORRESPONDENCE: ipprosecutionsf@orrick.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): beth.goldman@orrick.com; blee@orrick.com; eaghnami@orrick.com; aparker@orrick.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Thomas Ottoboni/   Date: 09/10/2020
Signatory's Name: Thomas Ottoboni
Signatory's Position: Senior VP
Payment Sale Number: 90173827
Payment Accounting Date: 09/11/2020

Serial Number: 90173827
Internet Transmission Date: Fri Sep 11 09:10:30 ET 2020
TEAS Stamp: USPTO/BAS-X.XX.XXX.X-2020091109103093300
8-90173827-750b5ea1631129112a2787f227c97
597bf7ee1335f0ee15d7a7b1b0cdb4f598e9-DA-
10291109-20200910174321364276

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed